141 filings
Page 5 of 8
8-K
8t2c6 4as4dweq
26 Oct 20
Milestone Pharmaceuticals Announces Pricing of a Public Offering of $45 Million of Common Shares and Pre-Funded Warrants
4:04pm
424B5
axsx9lyv tsr
26 Oct 20
Prospectus supplement for primary offering
4:01pm
10-K/A
sqx4y53379ri7keqih
23 Oct 20
Annual report (amended)
4:02pm
S-3MEF
pbjk82 zbgmk800o51vw
22 Oct 20
Registration of additional securities for an S-3
9:57pm
424B5
qdr3t1234yzgd9
22 Oct 20
Prospectus supplement for primary offering
4:28pm
8-K
6s14wh z2pxe
22 Sep 20
Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments
7:30am
UPLOAD
tyb52yxcp0
27 Aug 20
Letter from SEC
12:00am
8-K
vfy0gbcig tvshb0rn
29 Jul 20
Entry into a Material Definitive Agreement
6:06am
424B5
lhf4e5rhu vi9ha1erqo
29 Jul 20
Prospectus supplement for primary offering
6:03am
8-K
gbol67wwi kurf
23 Jul 20
Milestone Pharmaceuticals Announces Regulatory Guidance and Updated Clinical Development Plan for Etripamil in PSVT
7:05am
EFFECT
zgj wfjuye
7 Jul 20
Notice of effectiveness
12:15am
CORRESP
4408o rrxgh3zb
1 Jul 20
Correspondence with SEC
12:00am
UPLOAD
2vyo2
25 Jun 20
Letter from SEC
12:00am
S-3
9pgxd4
19 Jun 20
Shelf registration
4:54pm
8-K
d2njtp6q 6fslm
9 Jun 20
Departure of Directors or Certain Officers
12:00am
DEFA14A
sr5ng zs1
5 May 20
Additional proxy soliciting materials
5:05pm